Page 11234..1020..»

Category Archives: Clinical Cardiology

US Heart & Vascular Expands to Kansas through Partnership with Heartland Cardiology – Yahoo Finance

Posted: Published on April 28th, 2023

The Heartland Partnership Represents USHVs First in Kansas. Continue reading

Posted in Clinical Cardiology | Comments Off on US Heart & Vascular Expands to Kansas through Partnership with Heartland Cardiology – Yahoo Finance

Proving AI in the Clinic: An Algorithm That Accurately Evaluates … – Stanford HAI

Posted: Published on April 28th, 2023

To gain approval by the FDA, drugs typically need to be proven safe and effective in rigorous, randomized clinical trials. Often, these trials are blinded: The patients and researchers do not know which patients received the standard treatment or the experimental treatment Continue reading

Posted in Clinical Cardiology | Comments Off on Proving AI in the Clinic: An Algorithm That Accurately Evaluates … – Stanford HAI

Metabolic syndrome with sleep apnea ups risk for heart events in … – Healio

Posted: Published on April 28th, 2023

April 21, 2023 2 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Back to Healio Women hospitalized with acute coronary syndrome who have metabolic syndrome are 1.7 times more likely to experience a major adverse CV or cerebrovascular event if they also have comorbid obstructive sleep apnea, researchers reported. Continue reading

Posted in Clinical Cardiology | Comments Off on Metabolic syndrome with sleep apnea ups risk for heart events in … – Healio

Dr. Rajesh Rajan: A Highly Decorated Cardiologist – BW Businessworld

Posted: Published on April 28th, 2023

When Dr. Rajesh Rajan chose cardiology as his field of study, he wanted to explore the numerous possibilities for heart patients around the world for better healthcare Continue reading

Posted in Clinical Cardiology | Comments Off on Dr. Rajesh Rajan: A Highly Decorated Cardiologist – BW Businessworld

While other hospitals struggle, SLV Health expands services and … – Valley Courier

Posted: Published on April 28th, 2023

Photo courtesy of SLV HealthDr Carla Christ, MD, General Surgery, poses with a Savi Scout. By: By John Waters, Courier News Editor Updated: 3 hours ago / Posted Apr 27, 2023 ALAMOSA Hospitals in rural areas are cornerstone institutions that offer a bevy of benefits to the communities they serve Continue reading

Posted in Clinical Cardiology | Comments Off on While other hospitals struggle, SLV Health expands services and … – Valley Courier

Outcomes poor after HF hospitalization for patients with mildly … – Healio

Posted: Published on April 28th, 2023

April 27, 2023 2 min read Disclosures: Greene reports receiving research support from Amgen, AstraZeneca, Bristol Myers Squibb, Cytokinetics, Merck, Novartis, Pfizer and Sanofi; serving on advisory boards for Amgen, AstraZeneca, Bristol Myers Squibb, Boehringer Ingelheim/Eli Lilly, Cytokinetics, Roche Diagnostics, scPharmaceuticals and Sanofi; receiving speaker fees from Boehringer Ingelheim, Cytokinetics and Roche Diagnostics; and serving as a consultant for Amgen, Bayer, Bristol Myers Squibb, Corteria Pharmaceuticals, CSL Vifor, Merck, PharmaIN, Roche Diagnostics, Sanofi, Tricog Health and Urovant Pharmaceuticals. Continue reading

Posted in Clinical Cardiology | Comments Off on Outcomes poor after HF hospitalization for patients with mildly … – Healio

Ultromics Granted FDA Breakthrough Device Designation for AI … – Diagnostic and Interventional Cardiology

Posted: Published on April 28th, 2023

April 27, 2023 Ultromics, a leader in the field of artificial intelligence-powered diagnostics for heart failure, has been granted FDA Breakthrough Device Status for its AI-enhanced platform for detecting cardiac amyloidosis. The platform, EchoGo Amyloidosis, uses artificial intelligence to analyze echocardiograms and detect the presence of cardiac amyloidosis, a condition caused by deposits of abnormal proteins in the heart tissue, using only a single commonly acquired ultrasound view of the heart. The novel technology is designed to address the unmet need for earlier diagnosis of amyloidosis patients, which otherwise may go unnoticed until the disease has advanced, delaying treatment, and adversely impacting patient outcomes. Continue reading

Posted in Clinical Cardiology | Comments Off on Ultromics Granted FDA Breakthrough Device Designation for AI … – Diagnostic and Interventional Cardiology

Nanomedicine Market Expected to Reach US$ 393.04 Billion by 2030 | CAGR 9.2% [PDF Version] – EIN News

Posted: Published on April 28th, 2023

PORTLAND, OR, UNITED STATE, April 27, 2023 /EINPresswire.com/ -- Nanomedicine Market- Global Outlook and Forecast 2023-2030 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2030). Continue reading

Posted in Clinical Cardiology | Comments Off on Nanomedicine Market Expected to Reach US$ 393.04 Billion by 2030 | CAGR 9.2% [PDF Version] – EIN News

Society for Clinical Trials Presents CHAP Trial with Prestigious David Sackett Trial of the Year Award – Newswise

Posted: Published on April 28th, 2023

Newswise Arlington Heights, Ill., April 27, 2023 -- The Society for Clinical Trials (SCT) is pleased to announce that the prestigious David Sackett Trial of the Year Award will be presented to The Chronic Hypertension and Pregnancy (CHAP) Trial. The award will be presented on May 24, 2023, as part of SCTs 44th Annual Meeting, Championing High-quality Evidence to Optimize Human Health, May 21 - 24 at the Baltimore Marriott Waterfront Hotel. Continue reading

Posted in Clinical Cardiology | Comments Off on Society for Clinical Trials Presents CHAP Trial with Prestigious David Sackett Trial of the Year Award – Newswise

Avidity Biosciences Announces Positive Topline Data from AOC … – PR Newswire

Posted: Published on April 28th, 2023

Topline data presented at AAN annual meeting showed AOC 1001 achieved directional improvements in multiple functional endpoint assessments - myotonia (vHOT), measures of strength (total QMT) and mobility (10mWRT, Timed Up and Go) AOC 1001 data demonstrate favorable safety/tolerability profile with most adverse events mild or moderate Topline AOC 1001 data identify dose range for pivotal study; Avidity continues to work to resolve partial clinical hold Volume 7 of investor and analyst event today at 5:30 p.m. ET in Boston and via webcast SAN DIEGO, April 27, 2023 /PRNewswire/ -- Avidity Biosciences, Inc Continue reading

Posted in Clinical Cardiology | Comments Off on Avidity Biosciences Announces Positive Topline Data from AOC … – PR Newswire

Page 11234..1020..»